AiNaNo.ru
Заметки о нанотехнологиях и не только
-
Tetragenetics G-SOME-Formulated Influenza Vaccine Provides Strong Protection Against H5N1 in Preclinical Efficacy Study
Я буду первым!Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza va…
Published on Январь 7, 2012 · Категории: Nanotech, Нанотехнологии;
